Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-α

Blood

Volumn 95, Issue 5, 2000, Pages 1642-1651

  Cotterell, Sara E J ^a   Engwerda, Christian R ^a   Kaye, Paul M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL FUNCTION; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HEMATOPOIESIS; IMMUNOHISTOLOGY; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0034161360     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.5.1642.005k10_1642_1651     Document Type: Article

References (72)

1. Lord BI, Testa, NG, Hendry JH. The relative spacial distributions of CFU-s and CFU-c in the normal mouse femur. Blood. 1975;46:65.
2. Crocker PR, Gordon S. Isolation and characterization of resident stromal macrophages and hematopoietic-cell clusters from mouse bone marrow. J Exp Med. 1985;162:993.
3. Simmons PJ, Levesque JP, Zannettino ACW. Adhesion molecules in haemopoiesis. Baillieres Clin Haematol. 1997;10:485
4. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a hematopoietic growth-factor (Gm-Csf) by glycosaminoglycans in the bone-marrow microenvironment. Nature. 1987;326:403.
5. Ogawa M. Differentiation and proliferation of hematopoietic stem-cells. Blood. 1993;81:2844.
6. Quesenberry PJ. Hemopoietic stem cells, progenitor cells, and cytokines. In: Beutler E, Lichtman MA, Coller BS, Kipps T J, eds. Williams Hematology. 5th ed. New York, NY: McGraw-Hill Inc; 1995:211.
7. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of stem cells in vitro. J Cell Physiol. 1977;91:335.
8. Quesenberry P, McElrath E, Buxton E, Kittler E, Crittendon R, Temeles D. Constitutive production of multiple hemopoietic growth factors by murine Dexter stroma. Blood 1990;76:161a.
9. Quesenberry PJ, Crittenden RB, Lowry P, et al. In-vitro and in-vivo studies of stromal niches. Blood Cells. 1994;20:97.
10. Tsuji T, Ogasawara H, Aoki Y, Tsurumaki Y, Kodama H. Characterization of murine stromal cell clones established from bone marrow and spleen. Leukemia. 1996;10:803.
11. Sensebe L, Deschaseaux M, Li J, Herve P, Charbord P. The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment. Stem Cells. 1997;15:133.
12. Zipori D, Friedman A, Tamir M, Silverberg D, Malik Z. Cultured mouse marrow cell-lines - interactions between fibroblastoid cells and monocytes. J Cell Physiol 1984;118:143.
13. Busch FW, Mutter W, Koszinowski UH, Reddehase MJ. Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone-marrow stroma. J Virol. 1991;65:981.
14. Sing GK, Ruscetti FW. The role of human cytomegalovirus in hematological diseases. Baillieres Clin Haematol. 1995;8:149.
15. Mori T, Nakamura M, Shimizu K, Ikeda Y, Ando K. In vivo disturbance of hematopoiesis in mice persistently infected with murine cytomegalovirus: impairment of stromal cell function. Virology. 1999;253:145.
16. Gibbons AE, Price P, Shellam GR. Analysis of hematopoietic stem and progenitor-cell populations in cytomegalovirus-infected mice. Blood, 1995;86:473.
17. Hamburger AW, Chen RB. Impaired ability of bone-marrow cells from immunodeficient mice to establish long-term cultures. Br J Haematol. 1993;85:646.
18. Peterson VM, Madonna GS, Vogel SN. Differential myelopoietic responsiveness of Balb/C (Itys) and C.D2 (Ityr) mice to lipopolysaccharide administration and salmonella-typhimurium infection. Infect Immun. 1992;60:1375.
19. Hamburger AW. Impaired cytokine production by bone-marrow stromal cells of immunodeficient mice. Br J Haematol. 1997;90:750.
20. Gallicchio VS, Tse KF, Morrow J, Hughes NK. Suppression of hematopoietic support function is associated with overexpression of interleukin-4 and transforming growth factor-beta 1 in LP-BM5 murine-leukemia-virus-infected stromal cell lines. Acta Haematol. 1996;95:204.
21. Asami M, Owhashi M, Abe T, Nawa Y. A comparative-study of the kinetic changes of hematopoietic stem-cells in mice infected with lethal and nonlethal malaria. Int J Parasitol. 1992;22:43.
22. Weiss L, Johnson J, Weidanz W. Mechanisms of splenic control of murine malaria - tissue-culture studies of the erythropoietic interplay of spleen, bone-marrow, and blood in lethal (strain-17xl) Plasmodium yoelii malaria in Balb/C Mice. Am J Trop Med Hyg. 1989;41:135.
23. Dutra HS, Rossi MID, Azevedo SP, ElCheikh MC, Borojevic R. Haematopoietic capacity of colonyforming cells mobilized in hepatic inflammatory reactions as compared to that of normal bone marrow cells. Res Immunol. 1997;148:437.
24. Clark CR, Chen BDM, Boros DL. Macrophage progenitor-cell and colony-stimulating factor production during granulomatous schistosomiasis mansoni in mice. Infect Immun. 1988;56:2680.
25. Mirkovich AM, Galelli A, Allison AC, Modabber FZ. Increased myelopoiesis during leishmania-major infection in mice - generation of safe targets, a possible way to evade the effector immune mechanism. Clin Exp Immunol. 1986;64:1.
26. Lelchuk R, Graveley R, Liew FY. Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin-3 in response to leishmania antigen in vitro. Cell Immunol. 1988;111:66.
27. Murray HW, Squires KE, Miralles CD, et al. Acquired resistance and granuloma formation in experimental visceral leishmaniasis: differential T cell and lymphokine roles in initial versus established immunity. J Immunol. 1992;148:1858.
28. Engwerda CR, Smelt SC, Kaye PM. An in vivo analysis of cytokine production during Leishmania donovani infection in scid Mice [Full text delivery]. Exp Parasitol. 2996;84:195.
29. Stern JJ, Oca MJ, Rubin BY, Anderson SL, Murray HW. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J Immunol. 1988;140:3971.
30. Cervia JS, Rosen H, Murray HW. Effector role of blood monocytes in experimental visceral leishmaniasis. Infect Immun. 1993;61:1330.
31. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur J Immunol. 1998;28:669.
32. Tumang MC, Keogh C, Moldawer LL, et al. Role and effect of TNF-alpha in experimental visceral leishmaniasis. J Immunol. 1994;153:768.
33. Murray HW, Miralles GD, Stoeckle MY, McDermott DF. Role and effect of IL-2 in experimental visceral leishmaniasis. J Immunol. 1993;151:929.
34. Squires KE, Schreiber RD, McElrath MJ, Rubin BY, Anderson SL, Murray HW. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J Immunol. 1989;143:4244.
35. Smelt SC, Engwerda CR, McCrossen M, Kaye PM. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol. 1997;158:3813.
36. Saha B, Nandaroy H, Pakrashi A, Chakrabarti RN, Roy S. Immunobiological studies on experimental visceral leishmaniasis: 1. Changes in lymphoid organs and their possible role in pathogenesis. Eur J Immunol. 1991;21:577.
37. Derigs HG, Burgess GS, Klingberg D, et al. Role for cyclic-AMP in the postreceptor control of cytokine-stimulated stromal cell-growth factor production. Leukemia. 1990;4:471.
38. Zipori D, Duksin D, Tamir M, Argaman A, Toledo J, Malik Z. Cultured mouse marrow stromal cell-lines: 2. Distinct subtypes differing in morphology, collagen types, myelopoietic factors, and leukemic-cell growth modulating activities. J Cell Physiol. 1985;122:81.
39. Lee KH, Kinashi T, Tohyama K, et al. Different stromal cell-lines support lineage-selective differentiation of the multipotential bone-marrow stemcell clone Lyd9. J Exp Med. 1991;173:1257.
40. Spooncer E, Heyworth CM, Dunn A, Dexter TM. Self-renewal and differentiation of interleukin-3-dependent multipotent stem-cells are modulated by stromal cells and serum factors. Differentiation. 1986;31:111.
41. Ichimiya I, Kawauchi H, Fujiyoshi T, Tanaka T, Mogi G. Distribution of immunocompetent cells in normal nasal mucosa: comparisons among germ-free, specific pathogen-free, and conventional mice. Ann Otol Rhinol Laryngol. 1991;100:638.
42. Mclean IW, Nakane PK. Pariodate-lysine-parafor-maldehyde fixative: a new fixative for immuno-electron microscopy. J Histochem Cytochem. 1974;22:1077.
43. Heyworth CM, Spooncer E. In vitro clonal assays for murine multipotential and lineage restricted myeloid progenitor cells. In: Testa NG, Molineux G, eds. Haemopoiesis - A Practical Approach, vol. 2. Oxford, IRL; 1993:37.
44. Murphy E, Hieny S, Sher A, Ogarra A. Detection of in-vivo expression of interleukin-10 using a semiquantitative polymerase chain-reaction method in Schistosoma mansoni-infected mice. J Immunol Methods. 1993;162:211.
45. O'Garra A, Stapleton G, Dhar V, et al. Production of cytokines by mouse B-cells - B-lymphomas and normal B-cells produce interleukin-10. Int Immunol. 1990;2:821.
46. Peterson VM, Adamovicz JJ, Elliott TB, et al. Gene-expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma-irradiation and is differentially enhanced by therapeutic administration of biologic response modifiers. J Immunol. 1994;153:2321.
47. Rhoades ER, Cooper AM, Orme IM. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun. 1995;63:3871.
48. Lin GS, Finger E, Gutierrezramos JC. Expression of Cd34 in endothelial-cells, hematopoietic progenitors and nervous cells in fetal and adult-mouse tissues. Eur J Immunol. 1995;25:1508.
49. Krause DS, Fackler MJ, Civin CI. May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87:1.
50. Crocker PR, Werb Z, Gordon S, Bainton DF. Ultrastructural-localization of a macrophage-restricted sialic-acid binding hemagglutinin, Ser, in macrophage-hematopoietic cell clusters. Blood. 1990;76:1131.
51. Kinashi T, Tashiro K, Takeda T, Palacios R, Honjo T. An interleukin-4-dependent precursor clone is an intermediate of the differentiation pathway form an interleukin-3-dependent precursor clone to myeloid as well as B lymphocytes. Int Immunol. 1989;1:11.
52. Takeda S, Gillis S, Palacios R. In vitro effects of recombinant interleukin-7 on growth and differentiation of bone marrow pro-B- and pro-T-lymphocyte clones and fetal thymocyte clones. Proc Natl Acad Sci U S A. 1989;86:1634.
53. Kinashi T, Inaba K, Tsubata T, Tashiro K, Palacios R, Honjo T. Differentiation of an interleukin 3-dependent precursor B-cell clone into immunoglobulin-producing cells-in vitro. Proc Natl Acad Sci U S A. 1988;85:4473.
54. Eaves CJ. Assays of hemopoietic progenitor cells. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology, 5th ed. New York, NY: McGraw-Hill; 1995:L22.
55. Maze R, Sherry B, Kwon BS, Cerami A, Broxmeyer HE. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1-alpha. J Immunol. 1992;149:1004.
56. Dunlop DJ, Wright EG, Lorimore S, et al. Demonstration of stem-cell inhibition and myeloprotective effects of Sci/Rhmip1-alpha in vivo. Blood. 1992;79:2221.
57. Bonnet D, Lemoine FM, Najman A, Guigon M. Comparison of the inhibitory effect of ACSDKP, TNFa, TGFb and MIP1a on marrow purified CD34-progenitors. Exp Hematol. 1995;25:551.
58. Broxmeyer HE, Sherry B, Lu L, et al. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone-marrow myeloid progenitor cells. Blood. 1990;76:1110.
59. Keller JR, Bartelmez SH, Sitnicka E, et al. Distinct and overlapping direct effects of macrophage inflammatory protein-1-alpha and transforming growth-factor-beta on hematopoietic progenitor stem-cell growth. Blood. 1994;84:2175.
60. Leclercq V, Lebastard M, Belkaid Y, Louis J, Milon G. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice - a tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol. 1996;157:4537.
61. Metcalf D. Control of granulocytes and macrophages - molecular, cellular, and clinical aspects. Science. 1991;254:529.
62. Ichikawa Y, Pluznik DH, Sachs L. In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A. 1966;56:488.
63. Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood. 1991;77:1131.
64. Sonoda Y, Yang YC, Wong GG, Clark SC, Ogawa M. Analysis in serum-free culture of the targets of recombinant human hematopoietic growth-factors - interleukin-3 and granulocyte macrophage-colony-stimulating factor are specific for early developmental stages. Proc Natl Acad Sci U S A. 1988;85:4360.
65. Donahue RE, Emerson SG, Wang EA, Wong GG, Clark SC, Nathan DG. Demonstration of burst-promoting activity of recombinant human Gm-Csf on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin. Blood. 1985;66:1479.
66. Lyman SD, Jacobsen SEW. c-kit Ligand and flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1996;91:1101.
67. Dignass AU, Podolsky DK, Rachmilewitz D. Nox generation by cultured small-intestinal epithelial-cells. Dig Dis Sci 1995;40:1859.
68. Sensebe L, Mortensen BT, Fixe P, Herve P, Charbord P. Cytokines active on granulomonopoiesis: release and consumption by human marrow myeloid stromal cells. Br J Haematol. 1997;98:274.
69. Gorak PMA, Engwerda CR, Kaye PM. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol. 1998;28:687.
70. Kaye PM, Bancroft GJ. Leishmania donovani infection in Scid mice - lack of tissue-response and in vivo macrophage activation correlates with failure to trigger natural-killer cell-derived gamma interferon-production in vitro. Infect Immun. 1992;60:4335.
71. Backx B, Broeders L, Bot FJ, Lowenberg B. Positive and negative effects of tumor-necrosis-factor on colony growth from highly purified normal marrow progenitors. Leukemia. 1991;5:66.
72. Cotterell SEJ, Engwerda CR, Kaye PM. Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani. Infect Immun. 2000; in press.